Purchases and Sales Made in Q4 2022 in Rubius Therapeutics, Inc. (RUBY)
This table provides information about the institutional ownership of Rubius Therapeutics, Inc. (RUBY) during Q4 2022. The information is specifically focused on institutions that hold shares of Rubius Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
615K+ 92.73% |
$86K - $191K
|
1.28M
$0
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
71.6K+ 55.68% |
$10K - $22.2K
|
200K
$0
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
60.7K+ 506.22% |
$8.49K - $18.8K
|
72.7K
$0
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
BUY
|
- |
57.7KNew |
$8.08K - $17.9K
|
57.7K
$0
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
41.3K+ 150.39% |
$5.79K - $12.8K
|
68.8K
$0
|
|
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
21KNew |
$2.94K - $6.51K
|
21K
$0
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
19.2KNew |
$2.69K - $5.95K
|
19.2K
$0
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
16.1K+ 501.37% |
$2.25K - $4.98K
|
19.3K
$0
|
|
Jan 24, 2023
Q4 2022
|
Baillie Gifford & CO
|
BUY
|
- |
15.4K+ 0.32% |
$2.15K - $4.76K
|
4.87M
$0
|
|
Feb 10, 2023
Q4 2022
|
New York Life Investment Management LLC
New York, NY |
BUY
|
- |
10.9K+ 11.94% |
$1.53K - $3.38K
|
102K
$0
|
|
Feb 03, 2023
Q4 2022
|
New England Capital Financial Advisors LLC
Meriden, CT |
BUY
|
- |
1.11KNew |
$155 - $343
|
1.11K
$0
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
325New |
$45.5 - $101
|
325
$0
|
|
Feb 15, 2023
Q4 2022
|
Steward Partners Investment Advisory, LLC
|
BUY
|
- |
200New |
$28 - $62
|
200
$0
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
- |
56+ 4.35% |
$7.84 - $17.4
|
1.34K
$0
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
8+ 2.61% |
$1.12 - $2.48
|
314
$0
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 09, 2023
Q4 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-1- 0.01% |
$0.14 - $0.31
|
9.92K
$0
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-127- 0.18% |
$17.8 - $39.4
|
71.4K
$0
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-456- 99.35% |
$63.8 - $141
|
3
$0
|
|
Jan 25, 2023
Q4 2022
|
Clarius Group, LLC
Seattle, WA |
SELL
|
- |
-1.28K- 5.65% |
$179 - $397
|
21.4K
$0
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.56K- 61.86% |
$499 - $1.1K
|
2.2K
$0
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-9.46K- 6.67% |
$1.32K - $2.93K
|
132K
$0
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-14.1K- 18.42% |
$1.97K - $4.36K
|
62.3K
$0
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-16.5K- 99.85% |
$2.31K - $5.12K
|
25
$0
|
|
Feb 07, 2023
Q4 2022
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-17K- 30.18% |
$2.38K - $5.27K
|
39.3K
$0
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-23.4K- 5.38% |
$3.28K - $7.26K
|
412K
$0
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-27K- 60.67% |
$3.78K - $8.37K
|
17.5K
$0
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-27K- 60.67% |
$3.78K - $8.37K
|
17.5K
$0
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-28.6K- 1.68% |
$4.01K - $8.87K
|
1.68M
$0
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-55.2K- 24.56% |
$7.73K - $17.1K
|
170K
$0
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-390K- 24.59% |
$54.7K - $121K
|
1.2M
$0
|